Skip to main content
Clinical Trials/NCT04776928
NCT04776928
Completed
Not Applicable

Testing a Provider-Level Feedback Intervention to Optimize Postoperative Prescribing - Aim 3 Phase 1

University of Michigan1 site in 1 country217 target enrollmentMarch 17, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Opioid Prescribing
Sponsor
University of Michigan
Enrollment
217
Locations
1
Primary Endpoint
Change in Opioid Prescribed Following the Intervention
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The objective of this project is to leverage the Michigan Surgical Quality Collaborative's (MSQC) existing network and surgeon performance feedback platform to improve opioid prescribing practices for surgeons within the network found to be prescribing in a manner discordant with published guidelines and to inform best practices for future surgical quality improvement initiatives.

The study is being completed to learn more about the effectiveness, feasibility, and acceptability and that the goal is both to evaluate how effective this intervention and mechanism are for changing surgeon opioid prescribing behavior and to inform best practices for future quality initiatives. The study hypothesizes that provider-level feedback will allow clinicians to tailor postoperative prescribing more closely to patient consumption, and reduce excess postoperative prescribing.

The cohort of surgeons which have been identified as outliers by the Michigan Surgical Quality Collaborative (MSQC) will be be invited to participate in this trial. The study team will send surgeons belonging to sites that signed the Exhibit B-1 form the provider-level push notifications (98 participants). In this study de-identified prescribing data will also be analyzed for sites that do not sign the Exhibit B-1 form (105 participants).

The study team will approach 98 surgeons receiving the provider-level push notifications in one wave.

Registry
clinicaltrials.gov
Start Date
March 17, 2022
End Date
August 17, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jennifer Waljee

Associate Professor of Surgery and Associate Professor of Orthopaedic Surgery

University of Michigan

Eligibility Criteria

Inclusion Criteria

  • Surgeons already participating in and sharing data with the Michigan Surgical Quality Collaborative (MSQC) who perform procedures of interest
  • Surgeons within MSQC who have median prescribing \> 1 pill equivalents over the published recommendation
  • Surgeons within MSQC who perform surgeries at a hospital that have agreed to participate in this research

Exclusion Criteria

  • Surgeons not identified in the MSQC data as having a valid National Provider Identifier (NPI)

Outcomes

Primary Outcomes

Change in Opioid Prescribed Following the Intervention

Time Frame: up to 5 months from enrollment

Oral morphine equivalents prescribed adjusted for surgery type as reported through MSQC data.

Study Sites (1)

Loading locations...

Similar Trials